Stilwell Takes 9.9% Activist Investor Stake in CSB Financial
Joseph Stilwell's funds disclosed a 9.9% activist investor stake in Ohio's CSB Financial in an August 2026 Schedule 13D, citing undervalued bank assets.
The news
A group led by Joseph Stilwell disclosed an activist investor stake in CSB Financial Inc., the holding company based in Bethel, Ohio, in a Schedule 13D filed August 6, 2026. The reporting persons, Stilwell Activist Fund, L.P., Stilwell Activist Investments, L.P., Stilwell Partners, L.P., Stilwell Value LLC and Stilwell himself, reported owning 139,000 shares, or 9.9% of the 1,402,935 shares outstanding. The date of the event requiring the filing was July 30, 2026.
The filing breaks down the cost by fund: Stilwell Activist Fund paid $239,400 for 19,000 shares; Stilwell Activist Investments paid $1,261,624.61 for 100,000 shares; and Stilwell Partners paid $252,656 for 20,000 shares. The money came from working capital, with margin loans available.
Item 4 states that the group bought the shares to profit from appreciation in the market price and by asserting shareholder rights, and that it believes the value of the company’s assets is not adequately reflected in its share price. The group said it intends to work with management and the board to maximize shareholder value. An exhibit to the filing recounts the group’s long history of engagements with publicly traded companies, including pushes for sales and mergers, board nominations and share repurchases.
Our analysis
Stilwell is one of the most recognizable names in small-bank activism, and the exhibit attached to the filing is effectively a résumé meant to be read by the target’s board. It catalogs prior campaigns, from negotiated board seats to proxy contests and litigation, and notes that many past targets were eventually sold. For a small holding company, receiving a 13D with that history attached signals that the investor is prepared for a long engagement.
The stake sits just under 10%, a level that, for bank holding companies, generally stays below thresholds that can trigger additional regulatory review of control. Stopping at 9.9% lets an activist maximize influence while avoiding that process.
The total cost of about $1.75 million, by our addition of the three amounts, is modest in absolute terms. That reflects how small CSB Financial is, with roughly 1.4 million shares outstanding. In companies this size, an investor with nearly 10% can carry real weight in shareholder votes, especially where turnout is low.
The breakdown of purchase costs offers a rough sense of entry prices. Stilwell Activist Fund paid an average of about $12.60 per share, while Stilwell Activist Investments and Stilwell Partners paid roughly $12.62 and $12.63, by our division of the reported totals. The consistency suggests the shares were bought over a relatively narrow price range.
The Item 4 language follows the group’s established playbook: an assertion that assets are undervalued, paired with a stated preference to work cooperatively. In past campaigns, the group’s stated objectives have included share buybacks below book value, board representation and, in many cases, a sale of the institution.
Room for disagreement
Management and some shareholders could argue that a small community bank serves local customers and long-term holders best by staying independent, and that pressure for a sale prioritizes short-term returns. Others would counter that small banks often trade at discounts to their underlying value because of limited liquidity and scale, and that an activist can help close that gap through buybacks or a merger with a larger institution. The filing itself does not yet make a specific demand, so the direction of the campaign is still open.
What to watch
Watch for 13D amendments that disclose letters to the board, requests for board seats or nominations for the next annual meeting, any share repurchase program announced by CSB Financial, and signs of strategic review, which in past Stilwell campaigns has sometimes preceded a sale.
Prepared with AI assistance from public sources and reviewed under our editorial policy. Not investment advice.